Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by cytochromeon Feb 13, 2017 10:16am

145 Views

Post# 25836803

RE:RE:RE:Micro Analysis

That's a ridiculous statement. Count the millions? Based on what exactly??
Selling extremely expensive modalities is not an easy task and when there are
many laser devices out there considerably cheaper. With no proven clinical track record, sales of TLC 2000 will be very slow to increase.....and will most likely never be profitable given the expenses reported to sell them.
I will wait for the resident know it alls to chime in and tell me I'm a basher blah blah blah.....
And then the numbers will come out and the excuses will flow yet again........sad!

Bullboard Posts

Three micro-cap value stocks trading at peak pessimism